News and Announcements
Big Potential for New FR Treatment
- Published March 01, 2012 7:39PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alexium reports that it is entering the commercial rollout phase of flame retardant, oil/water repellent nylon. The eco-friendly flame retardant treatment is based on a new flame retardant mechanism that Alexium has discovered and developed for nylon fabrics. The treatment has met key technical milestones for flame retardancy, water repellency, and durability.
Alexium will now be entering larger demonstration runs for interested partners and enter into certification testing for military and commercial customers. In the coming months, Alexium will be negotiating license agreements with partners to deliver FR nylon treatment capabilities to fabric producing partners, addressing the demand from military and commercial customers in the United States and abroad.
——
To view the full article, please click the link below.
To know more about Alexium International Group Limited, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
